Retinal Diseases  >>  acrizanib (LHA510)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
acrizanib (LHA510) / Novartis
NCT02076919: First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration

Completed
1
110
US
LHA510 Ophthalmic Suspension, LHA510 Vehicle
Alcon Research
Age-Related Macular Degeneration
06/14
06/14

Download Options